Sara Marinelli

Title: Sara Marinelli: Innovator in Therapeutic Applications

Introduction

Sara Marinelli is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of medicine, particularly in the therapeutic use of neurotoxins and pain management. With a total of four patents to her name, Marinelli is recognized for her innovative approaches to treating complex medical conditions.

Latest Patents

Among her latest patents, one notable invention is the therapeutic use of botulinum neurotoxin serotype A. This patent describes a new therapeutic application of botulinum neurotoxin serotype A (Bont/A) for treating paralysis caused by spinal cord injury. Another significant patent focuses on a method for potentiating the effects of opioid analgesics on pain. This invention involves the use of an anti-TrkA antibody that inhibits the binding between nerve growth factor (NGF) and TrkA, combined with at least one opioid analgesic for preparing a medicament aimed at treating and preventing pain.

Career Highlights

Sara Marinelli has worked with notable companies such as Lay Line Genomics S.p.A. and the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). Her work in these organizations has allowed her to advance her research and contribute to the development of innovative medical solutions.

Collaborations

Throughout her career, Marinelli has collaborated with esteemed colleagues, including Flaminia Pavone and Gabriele Ugolini. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in her field.

Conclusion

Sara Marinelli stands out as an influential inventor whose work in therapeutic applications has the potential to transform medical treatments. Her innovative patents and collaborations reflect her commitment to advancing healthcare solutions.